Biomarker profile and risk stratification in cardiovascular disease during pregnancy: Action to move forward
Emerging role of novel and traditional biomarkers in the diagnosis and risk stratification of pregnant women with cardiovascular disease (CVD) are needed to raise the standard of care and optimizing management. Biomarkers that reliably distinguish women at high risk for complication would provide a...
Guardado en:
Autores principales: | Hasan Ali Farhan, Israa Fadhil Yaseen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/69a1f97577ea459180efc6e334359e09 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Counselling and pregnancy outcomes in women with congenital heart disease- current status and gap analysis from Madras Medical College Pregnancy And Cardiac disease (M-PAC) registry
por: Justin Paul Gnanaraj, et al.
Publicado: (2021) -
Cardiovascular clinical trials in Africa: opportunities and challenges
por: Marli Terblanche, et al.
Publicado: (2017) -
Pregnancy in women with left-to-right cardiac shunts: Any risk?
por: Marla A. Mendelson
Publicado: (2021) -
Perceptions of the Cardiologists and Oncologists: Initial Step for Establishing Cardio-Oncology Service
por: Hasan Ali Farhan, et al.
Publicado: (2021) -
Cardiovascular Morbidity and Mortality in Adult Patients With Repaired Aortic Coarctation
por: Timion A. Meijs, et al.
Publicado: (2021)